However, the effect of indoxyl sulfate on cellular autophagy can be prevented by suppressing m6A or knocking down FTO using 3-deazaadenosine (DAA), offering a new approach to treating CKD by targeting m6A RNA modification (95). Here, FTO is linked to chronic kidney disease.